Back to top
more

Evolent Health (EVH)

(Real Time Quote from BATS)

$28.07 USD

28.07
186,342

+0.42 (1.52%)

Updated Apr 29, 2024 12:50 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.20%
2Buy18.04%
3Hold9.52%
4Sell5.20%
5Strong Sell2.60%
S&P50011.13%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 252)

Industry: Internet - Software

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Evolent Health (EVH) Earnings Expected to Grow: Should You Buy?

by Zacks Equity Research

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

What Makes Evolent Health (EVH) a Good Fit for "Trend Investing"

by Zacks Equity Research

Evolent Health (EVH) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our shorter-term trading strategy-based screen.

Here's Why Evolent Health (EVH) is a Great Momentum Stock to Buy

by Zacks Equity Research

Does Evolent Health (EVH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Has Evolent Health (EVH) Outpaced Other Computer and Technology Stocks This Year?

by Zacks Equity Research

Here is how Evolent Health (EVH) and KT Corp. (KT) have performed compared to their sector so far this year.

Has eGain (EGAN) Outpaced Other Computer and Technology Stocks This Year?

by Zacks Equity Research

Here is how eGain (EGAN) and Evolent Health (EVH) have performed compared to their sector so far this year.

Evolent Health (EVH) is on the Move, Here's Why the Trend Could be Sustainable

by Zacks Equity Research

Evolent Health (EVH) made it through our "Recent Price Strength" screen and could be a great choice for investors looking to make a profit from stocks that are currently on the move.

Wall Street Analysts Believe Evolent Health (EVH) Could Rally 38%: Here's is How to Trade

by Zacks Equity Research

The mean of analysts' price targets for Evolent Health (EVH) points to a 37.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.

Has Airgain (AIRG) Outpaced Other Computer and Technology Stocks This Year?

by Zacks Equity Research

Here is how Airgain (AIRG) and Evolent Health (EVH) have performed compared to their sector so far this year.

Best Momentum Stocks to Buy for May 25th

by Zacks Equity Research

CIB, IOSP, and EVH made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on May 25, 2022.

Can Evolent Health (EVH) Climb 39% to Reach the Level Wall Street Analysts Expect?

by Zacks Equity Research

The consensus price target hints at a 38.6% upside potential for Evolent Health (EVH). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.

Zendesk (ZEN) Misses Q4 Earnings Estimates

by Zacks Equity Research

Zendesk (ZEN) delivered earnings and revenue surprises of -11.11% and 1.59%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Digital Turbine (APPS) Q3 Earnings and Revenues Surpass Estimates

by Zacks Equity Research

Digital Turbine (APPS) delivered earnings and revenue surprises of 13.95% and 6.34%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Paylocity (PCTY) Q2 Earnings and Revenues Beat Estimates

by Zacks Equity Research

Paylocity (PCTY) delivered earnings and revenue surprises of 56.10% and 4.35%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Evolent Health (EVH) Reports Q3 Loss, Misses Revenue Estimates

by Zacks Equity Research

Evolent Health (EVH) delivered earnings and revenue surprises of 0.00% and -1.64%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Evolent Health (EVH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release

by Zacks Equity Research

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Evolent Health (EVH) Reports Q2 Loss, Tops Revenue Estimates

by Zacks Equity Research

Evolent Health (EVH) delivered earnings and revenue surprises of 66.67% and 2.34%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Evolent Health (EVH) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release

by Zacks Equity Research

Evolent Health (EVH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Are You Looking for a Top Momentum Pick? Why Evolent Health (EVH) is a Great Choice

by Zacks Equity Research

Does Evolent Health (EVH) have what it takes to be a top stock pick for momentum investors? Let's find out.

Evolent Health (EVH) Reports Q1 Loss, Tops Revenue Estimates

by Zacks Equity Research

Evolent Health (EVH) delivered earnings and revenue surprises of 87.50% and 2.33%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Will Evolent Health (EVH) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Phunware (PHUN) Surges: Stock Moves 9.9% Higher

by Zacks Equity Research

Phunware (PHUN) saw a big move last session, as its shares jumped nearly 10% on the day, amid huge volumes.

Will Evolent Health (EVH) Report Negative Earnings Next Week? What You Should Know

by Zacks Equity Research

Evolent Health (EVH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

eGain (EGAN) Hits 52-Week High, Can the Run Continue?

by Zacks Equity Research

eGain (EGAN) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Evolent Health (EVH) Reports Q2 Loss, Lags Revenue Estimates

by Zacks Equity Research

Evolent Health (EVH) delivered earnings and revenue surprises of 70.00% and -1.00%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

Chegg (CHGG) to Report Q2 Earnings: What's in the Offing?

by Zacks Equity Research

Benefits from remote learning and rising subscribers are likely to get reflected in Chegg's (CHGG) Q2 performance.